Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Schaefer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biotechnology Journal|June 3, 2010
Editorial: Methods for systems metabolic engineering and downstream processingUta Schaefer
Biotechnology Journal|January 14, 2010
Editorial: the impact of biotechBarbara Janssens, Uta Schaefer
Immunology|May 30, 2009
Following TRAIL's path in the immune systemChristina Falschlehner, Uta Schaefer, Henning Walczak
Biotechnology Journal|December 15, 2010
Editorial: A big "thank you" to BarbaraUta Schaefer, Sang Yup Lee, Alois Jungbauer
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
TRAIL: a multifunctional cytokineUta Schaefer, Oksana Voloshanenko, Daniela Willen, et al.
Advances in Experimental Medicine and Biology|September 18, 2009
TRAIL and other TRAIL receptor agonists as novel cancer therapeuticsChristina Falschlehner, Tom M Ganten, Ronald Koschny, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancyEsther H J Wissink, Inge Verbrugge, Stefan R Vink, et al.
The Journal of Clinical Investigation|December 15, 2007
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor developmentAnne Grosse-Wilde, Oksana Voloshanenko, S Lawrence Bailey, et al.
Gastroenterology|March 2, 2010
Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cellsFrederik J H Hoogwater, Maarten W Nijkamp, Niels Smakman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biotechnology Journal|June 3, 2010
Editorial: Methods for systems metabolic engineering and downstream processingUta Schaefer
Biotechnology Journal|January 14, 2010
Editorial: the impact of biotechBarbara Janssens, Uta Schaefer
Immunology|May 30, 2009
Following TRAIL's path in the immune systemChristina Falschlehner, Uta Schaefer, Henning Walczak
Biotechnology Journal|December 15, 2010
Editorial: A big "thank you" to BarbaraUta Schaefer, Sang Yup Lee, Alois Jungbauer
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
TRAIL: a multifunctional cytokineUta Schaefer, Oksana Voloshanenko, Daniela Willen, et al.
Advances in Experimental Medicine and Biology|September 18, 2009
TRAIL and other TRAIL receptor agonists as novel cancer therapeuticsChristina Falschlehner, Tom M Ganten, Ronald Koschny, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancyEsther H J Wissink, Inge Verbrugge, Stefan R Vink, et al.
The Journal of Clinical Investigation|December 15, 2007
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor developmentAnne Grosse-Wilde, Oksana Voloshanenko, S Lawrence Bailey, et al.
Gastroenterology|March 2, 2010
Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cellsFrederik J H Hoogwater, Maarten W Nijkamp, Niels Smakman, et al.
Pageof 1